|
JP2005504789A
(ja)
*
|
2001-09-13 |
2005-02-17 |
シンタ ファーマスーティカルズ コーポレイション |
癌治療のための２−アロイルイミダゾール化合物
|
|
CA2475331C
(en)
*
|
2002-02-12 |
2012-06-12 |
Wisconsin Alumni Research Foundation |
Synthesis of indole thiazole compounds as ligands for the ah receptor
|
|
TW200503738A
(en)
*
|
2003-07-16 |
2005-02-01 |
Tzu Chi Buddhist General Hospital |
Method for extracting antineoplastic components from bupleurum scorzonerifolium
|
|
WO2005040345A2
(en)
*
|
2003-09-24 |
2005-05-06 |
Vertex Pharmceuticals Incorporated |
4-azole substituted imidazole compositions useful as inhibitors or c-met receptor tyrosine kinase
|
|
US7629332B2
(en)
*
|
2003-10-31 |
2009-12-08 |
Auckland Uniservices Limited |
Nitrophenyl mustard and nitrophenylaziridine alcohols and their corresponding phosphates and their use as targeted cytotoxic agents
|
|
GB0403781D0
(en)
*
|
2004-02-20 |
2004-03-24 |
Astrazeneca Ab |
Chemical compounds
|
|
AR051202A1
(es)
|
2004-09-20 |
2006-12-27 |
Xenon Pharmaceuticals Inc |
Derivados heterociclicos y su uso como inhibidores de la estearoil-coa desaturasa
|
|
CN101083992A
(zh)
|
2004-09-20 |
2007-12-05 |
泽农医药公司 |
抑制人硬脂酰CoA去饱和酶的哒嗪衍生物
|
|
TW200626154A
(en)
|
2004-09-20 |
2006-08-01 |
Xenon Pharmaceuticals Inc |
Heterocyclic derivatives and their use as therapeutic agents
|
|
WO2006034315A2
(en)
|
2004-09-20 |
2006-03-30 |
Xenon Pharmaceuticals Inc. |
Heterocyclic derivatives for the treatment of diseases mediated by stearoyl-coa desaturase enzymes
|
|
CA2580762A1
(en)
|
2004-09-20 |
2006-03-30 |
Xenon Pharmaceuticals Inc. |
Heterocyclic derivatives and their use as therapeutic agents
|
|
CN101084212A
(zh)
|
2004-09-20 |
2007-12-05 |
泽农医药公司 |
杂环衍生物及其作为硬脂酰CoA去饱和酶介导剂的用途
|
|
CA2580857A1
(en)
|
2004-09-20 |
2006-09-28 |
Xenon Pharmaceuticals Inc. |
Heterocyclic derivatives and their use as stearoyl-coa desaturase inhibitors
|
|
WO2006128129A2
(en)
*
|
2005-05-26 |
2006-11-30 |
Synta Pharmaceuticals Corp. |
Method for treating cancer
|
|
EP2540296A1
(en)
|
2005-06-03 |
2013-01-02 |
Xenon Pharmaceuticals Inc. |
Arminothiazole derivatives as human stearoyl-coa desaturase inhibitors
|
|
US20100256046A1
(en)
*
|
2009-04-03 |
2010-10-07 |
Tetralogic Pharmaceuticals Corporation |
Treatment of proliferative disorders
|
|
WO2007021825A2
(en)
*
|
2005-08-09 |
2007-02-22 |
Tetralogic Pharmaceuticals Corporation |
Treatment of proliferative disorders
|
|
WO2007062399A2
(en)
*
|
2005-11-23 |
2007-05-31 |
The Board Of Regents Of The University Of Texas System |
Oncogenic ras-specific cytotoxic compound and methods of use thereof
|
|
EP1998766A2
(en)
*
|
2005-12-16 |
2008-12-10 |
Ironwood Pharmaceuticals, Inc. |
Useful indole compounds
|
|
US7649098B2
(en)
*
|
2006-02-24 |
2010-01-19 |
Lexicon Pharmaceuticals, Inc. |
Imidazole-based compounds, compositions comprising them and methods of their use
|
|
US7501438B2
(en)
|
2006-07-07 |
2009-03-10 |
Forest Laboratories Holdings Limited |
Pyridoimidazole derivatives
|
|
WO2008085302A1
(en)
*
|
2006-12-20 |
2008-07-17 |
Merck & Co., Inc. |
Imidazopyridine analogs as cb2 receptor modulators, useful in the treatment of pain, respiratory and non-respiratory diseases
|
|
TW200920355A
(en)
*
|
2007-09-06 |
2009-05-16 |
Lexicon Pharmaceuticals Inc |
Compositions and methods for treating immunological and inflammatory diseases and disorders
|
|
JP5638955B2
(ja)
*
|
2007-10-26 |
2014-12-10 |
エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ |
Ｐｉ３キナーゼ阻害剤として有用なプリン誘導体
|
|
KR20110042153A
(ko)
|
2008-05-30 |
2011-04-25 |
제넨테크, 인크. |
퓨린 ｐｉ３ｋ 억제 화합물 및 사용 방법
|
|
EP2307414A4
(en)
*
|
2008-07-07 |
2011-10-26 |
Xcovery Holding Co Llc |
SELECTIVE INHIBITORS OF PI3 KINASE ISOFORMS
|
|
JP5781066B2
(ja)
|
2009-05-27 |
2015-09-16 |
ジェネンテック， インコーポレイテッド |
ｐ１１０δに対して選択的な二環式ピリミジンＰＩ３Ｋ阻害剤化合物及び使用方法
|
|
EP2560640A1
(en)
|
2010-04-19 |
2013-02-27 |
Synta Pharmaceuticals Corp. |
Cancer therapy using a combination of a hsp90 inhibitory compounds and a egfr inhibitor
|
|
US8293736B2
(en)
|
2010-07-14 |
2012-10-23 |
F. Hoffmann La Roche Ag |
Purine compounds selective for PI3K P110 delta, and methods of use
|
|
WO2012024620A2
(en)
|
2010-08-20 |
2012-02-23 |
Amira Pharmaceuticals, Inc. |
Autotaxin inhibitors and uses thereof
|
|
DK2651951T3
(en)
|
2010-12-16 |
2014-12-08 |
Hoffmann La Roche |
TRICYCLIC PI3K INHIBITOR COMPOUNDS AND PROCEDURES FOR USE THEREOF
|
|
EP2714680B1
(en)
|
2011-05-27 |
2015-11-25 |
Amira Pharmaceuticals, Inc. |
Heterocyclic autotaxin inhibitors and uses thereof
|
|
US20140286902A1
(en)
|
2011-11-02 |
2014-09-25 |
Synta Pharmaceuticals Corp. |
Combination therapy of hsp90 inhibitors with platinum-containing agents
|
|
AU2012332421A1
(en)
|
2011-11-02 |
2014-06-05 |
Synta Pharmaceuticals Corp. |
Cancer therapy using a combination of Hsp90 inhibitors with topoisomerase I inhibitors
|
|
US9402831B2
(en)
|
2011-11-14 |
2016-08-02 |
Synta Pharmaceutical Corp. |
Combination therapy of HSP90 inhibitors with BRAF inhibitors
|
|
CN108841778B
(zh)
*
|
2018-04-28 |
2022-05-17 |
大连普瑞康生物技术有限公司 |
一种红豆杉细胞组织培养物
|
|
EP4192828A1
(en)
|
2020-08-04 |
2023-06-14 |
Nura Bio, Inc. |
Substituted pyridine derivatives as sarm1 inhibitors
|
|
US11945796B2
(en)
|
2020-09-16 |
2024-04-02 |
Nura Bio, Inc. |
Substituted pyridine derivatives as SARM1 inhibitors
|
|
TW202313009A
(zh)
|
2021-07-28 |
2023-04-01 |
美商努拉生物科技公司 |
作為sarm1抑制劑之經取代的吡啶衍生物
|
|
WO2023064486A1
(en)
*
|
2021-10-14 |
2023-04-20 |
Galileo Biosystems, Inc. |
Aryl hydrocarbon receptor (ahr) modulators and therapeutic uses thereof
|